ALNYLAM PHARMACEUTICALS, INC. 4
4 · ALNYLAM PHARMACEUTICALS, INC. · Filed Feb 24, 2016
Insider Transaction Report
Form 4
Gros David-Alexandre C
SVP, Chief Business Officer
Transactions
- Purchase
Common Stock
2016-02-22$62.74/sh+100$6,274→ 100 total - Purchase
Common Stock
2016-02-22$62.75/sh+900$56,475→ 1,000 total
Footnotes (1)
- [F1]The open market purchase of Common Stock reported on this Form 4 was made by the reporting person on February 22, 2016.